Jonathan Robert Hunt - 02 Mar 2026 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role: Chief Accounting Officer
Signature: /s/ Jonathan Hunt by Chris Nenno, as Attorney-in-Fact
Issuer symbol: CATX
Transactions as of: 02 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2026, 16:35:18 UTC
Previous filing: 17 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hunt Jonathan Robert	Chief Accounting Officer	C/O PERSPECTIVE THERAPEUTICS, INC., 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE	/s/ Jonathan Hunt by Chris Nenno, as Attorney-in-Fact	04 Mar 2026	0001375410

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CATX	Stock option (right to buy)	Award		+90,000		$0.000000^*	90,000	02 Mar 2026	Common Stock	90,000	$5.35	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option grant was approved by the Compensation Committee of the Issuer's Board of Directors on February 4, 2026, with a grant date of March 2, 2026 (the "Grant Date"), and represents the Reporting Person's annual equity award for 2026.
F2	Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date.